Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104312 · ClinicalTrials.gov registry record
Osteoarthritis: Weakness From Inflammation
A clinical trial of Osteoarthritis, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT00104312: Completed study of Osteoarthritis, sponsored by National Institute on Aging (NIA).
NCT00104312 is a study of Osteoarthritis that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 88 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00104312, a study of Osteoarthritis, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the factors that lead to muscle weakness with arthritis and aging.
Conditions Studied
Study Locations (1)
Maryland
- Harbor Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2001-04 |
| Est. Completion | 2009-05 |
What the finished NCT00104312 record still lists
NCT00104312 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.
NCT00104312 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00104312 about?
NCT00104312 is a clinical study titled "Osteoarthritis: Weakness From Inflammation". The purpose of this study is to understand the factors that lead to muscle weakness with arthritis and aging.
What is the current status of trial NCT00104312?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2001-04. Estimated completion is 2009-05.
What conditions does trial NCT00104312 study?
This clinical trial studies the following conditions: Osteoarthritis.
Who is sponsoring clinical trial NCT00104312?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00104312 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00104312's enrollment target sits among peer trials
88 95th of 135 higher than 40 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04553770 · 88 participants · Phase 2
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia